Literature DB >> 33260381

Screening of Human CYP1A2 and CYP3A4 Inhibitors from Seaweed In Silico and In Vitro.

Sung-Kun Yim1, Kian Kim1, SangHo Chun1, TaeHawn Oh1, WooHuk Jung1, KyooJin Jung1, Chul-Ho Yun2.   

Abstract

Phenolic compounds and carotenoids are potential inhibitors of cytochrome P450s. Sixteen known compounds, phenolic compounds and carotenoids from seaweed were examined for potential inhibitory capacity against CYP1A2 and CYP3A4 in silico and in vitro. Morin, quercetin, and fucoxanthin inhibited the enzyme activity of CYP1A2 and CYP3A4 in a dose-dependent manner. The IC50 values of morin, quercetin, and fucoxanthin were 41.8, 22.5, and 30.3 μM for CYP1A2 and 86.6, 16.1, and 24.4 μM for CYP3A4, respectively. Siphonaxanthin and hesperidin did not show any significant effect on CYP1A2, but they slightly inhibited CYP3A4 activity at high concentrations. In silico modeling of CYP's binding site revealed that the potential inhibitors bound in the cavity located above the distal surface of the heme prosthetic group through the 2a or 2f channel of CYPs. This study presents an approach for quickly predicting CYP inhibitory activity and shows the potential interactions of compounds and CYPs through in silico modeling.

Entities:  

Keywords:  carotenoid; cytochrome P450; inhibitor prediction; molecular docking; phenolic compound

Mesh:

Substances:

Year:  2020        PMID: 33260381      PMCID: PMC7760626          DOI: 10.3390/md18120603

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


  34 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective.

Authors:  Thorir D Bjornsson; John T Callaghan; Heidi J Einolf; Volker Fischer; Lawrence Gan; Scott Grimm; John Kao; S Peter King; Gerald Miwa; Lan Ni; Gondi Kumar; James McLeod; R Scott Obach; Stanley Roberts; Amy Roe; Anita Shah; Fred Snikeris; John T Sullivan; Donald Tweedie; Jose M Vega; John Walsh; Steven A Wrighton
Journal:  Drug Metab Dispos       Date:  2003-07       Impact factor: 3.922

Review 3.  The ins and outs of cytochrome P450s.

Authors:  Vlad Cojocaru; Peter J Winn; Rebecca C Wade
Journal:  Biochim Biophys Acta       Date:  2006-07-21

4.  Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.

Authors:  T Shimada; M V Martin; D Pruess-Schwartz; L J Marnett; F P Guengerich
Journal:  Cancer Res       Date:  1989-11-15       Impact factor: 12.701

5.  Anti-mutagenic and anti-carcinogenic potential of the carotenoid meso-zeaxanthin.

Authors:  Alikunjhi P Firdous; Edakkadath R Sindhu; Viswanathan Ramnath; Ramadasan Kuttan
Journal:  Asian Pac J Cancer Prev       Date:  2010

Review 6.  Xenobiotic-metabolizing enzymes in human lung.

Authors:  Ji Y Zhang; Yuefen Wang; Chandra Prakash
Journal:  Curr Drug Metab       Date:  2006-12       Impact factor: 3.731

7.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility.

Authors:  Garrett M Morris; Ruth Huey; William Lindstrom; Michel F Sanner; Richard K Belew; David S Goodsell; Arthur J Olson
Journal:  J Comput Chem       Date:  2009-12       Impact factor: 3.376

8.  Prediction of Human Cytochrome P450 Inhibition Using a Multitask Deep Autoencoder Neural Network.

Authors:  Xiang Li; Youjun Xu; Luhua Lai; Jianfeng Pei
Journal:  Mol Pharm       Date:  2018-05-30       Impact factor: 4.939

9.  Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2.

Authors:  Stefaan Sansen; Jason K Yano; Rosamund L Reynald; Guillaume A Schoch; Keith J Griffin; C David Stout; Eric F Johnson
Journal:  J Biol Chem       Date:  2007-02-20       Impact factor: 5.157

10.  SuperCYPsPred-a web server for the prediction of cytochrome activity.

Authors:  Priyanka Banerjee; Mathias Dunkel; Emanuel Kemmler; Robert Preissner
Journal:  Nucleic Acids Res       Date:  2020-07-02       Impact factor: 16.971

View more
  4 in total

Review 1.  Fucoxanthin Is a Potential Therapeutic Agent for the Treatment of Breast Cancer.

Authors:  Tsz-Ying Lau; Hiu-Yee Kwan
Journal:  Mar Drugs       Date:  2022-05-30       Impact factor: 6.085

Review 2.  Candidate Proficiency Test Chemicals to Address Industrial Chemical Applicability Domains for in vitro Human Cytochrome P450 Enzyme Induction.

Authors:  Miriam Naomi Jacobs; Barbara Kubickova; Eugene Boshoff
Journal:  Front Toxicol       Date:  2022-06-20

3.  Protein-Ligand Identification and In Vitro Inhibitory Effects of Cathine on 11 Major Human Drug Metabolizing Cytochrome P450s.

Authors:  Sharoen Y M Lim; Jason Siau Ee Loo; Mustafa Alshagga; Mohammed A Alshawsh; Chin E Ong; Yan Pan
Journal:  Int J Toxicol       Date:  2022-06-04       Impact factor: 2.380

4.  In Vitro Hepatic Assessment of Cineole and Its Derivatives in Common Brushtail Possums (Trichosurus vulpecula) and Rodents.

Authors:  Ravneel R Chand; Mhairi Nimick; Belinda Cridge; Rhonda J Rosengren
Journal:  Biology (Basel)       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.